Dianthus Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Dianthus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Dianthus Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Dianthus Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $264k | 12k | 21.80 |
| 2024-09-30 | $291k | 11k | 27.38 |
| 2024-06-30 | $265k | 10k | 25.88 |
| 2024-03-31 | $481k | 16k | 30.00 |
| 2023-12-31 | $425 | 41 | 10.39 |
| 2023-09-30 | $559 | 41 | 13.66 |